In silico approach through molecular docking and study ADME on imine derivative compounds as a potential antibacterial agent against Staphylococcus aureus
DOI:
https://doi.org/10.46542/pe.2024.242.916Keywords:
ADME, Antibacterial, Docking, Imine, Staphylococcus aureusAbstract
Background: Antibiotics are drugs or compounds that inhibit or kill bacteria. Most natural and synthetic pharmacophores have been reported to be antimicrobial agents. One of these is an imine compound. Compounds containing imine groups exhibit various pharmacological activities, including antibacterial, antifungal, anti-HIV, anti-cancer, anti-inflammatory, antimalarial, and antituberculosis activities.
Objective: This study aimed to determine the potential of four imine-derived compounds as antibacterial agents using molecular docking.
Method: The molecular docking environment (MOE) 2022.0901 software package was used to perform molecular docking. Determination of the physicochemical and pharmacokinetic properties of the four imine-derivative compounds was performed online via the website www.swissadme.
Results: Based on the docking results, compound 1 has great potential as an antibacterial agent because its binding orientation was similar to that of the positive control. In addition, based on the Absorption, Distribution, Metabolism, and excretion (ADME) study, compound 1 was shown to be suitable for Lipinski's rule of five (RO5).
Conclusion: It can be concluded that compound 1 is easily absorbed, has good permeability, and can be used as a promising agent against Staphylococcus aureus.
References
Abrusan, G., & Marsh, J. A. (2019). Ligands and receptors with broad binding capabilities have common structural characteristics: An antibiotic design perspective. Journal of Medicinal Chemistry, 62(21), 9357–9374. https://doi.org/10.1021/acs.jmedchem.9b00220
Anuradha, B., Swati, S., & Sandeep, K. S. (2022). Molecular docking studies to identify promising natural inhibitors targeting SARS-CoV-2 Nsp10- Nsp16 protein complex. Turkish journal of pharmaceutical sciences, 19(1), 93–100. https://doi.org/10.4274/tjps.galenos.2021.56957
Batty, E. M., Cusack, T. P., Thaipadungpanit, J., Watthanaworawit, W., Carrara, V., Sihalath, S., Hopkins, J., Soeng, S., Ling, C., Turner, P., & Dance, D. A. B. (2020). The spread of chloramphenicol-resistant Neisseria meningitidis in Southeast Asia. International Journal of Infectious Diseases, 95, 198‒203. https://doi.org/10.1016/j.ijid.2020.03.081
Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the rule of 5 and drug ability. Advanced Drug Delivery Reviews, 101, 89. https://doi.org/10.1016/j.addr.2016.05.007
Chiemela, S. O., Elena, H., John, S., Zeeshan, A., Ming-Wei, C., Benita, P., Ian, H. W., Marco, M., Shina Caroline, L. K., & Philippe, B. W. (2022). In Silico ligand docking approaches to characterise the binding of known allosteric modulators to the glucagon-like peptide 1 receptor and prediction of ADME/Tox properties. Applied Biosciences, 1(2), 143–162. https://doi.org/10.3390/applbiosci1020010)
Cournia, Z., Allen, B., & Sherman, W. (2017). Relative binding free energy calculations in drug discovery: Recent advances and practical considerations. Journal Chemical Information Modeling, 57(12), 2911–2937. https://doi.org/10.1021/acs.jcim.7b00564
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 1–13. https://doi.org/10.1038/srep42717
Frimayanti, N., Marzieh, Y., Ihsan, I., Dhea, R.W.P., Hamid, N., & Fatemeh, S.B. (2021). Insight on the in silico study and biological activity assay of chalcone-based 1, 5-benzothiazepines as potential inhibitor for breast cancer MCF7. Chiang Mai University Journal of Natural Sciences, 20(1): e2021019. https://doi.org/10.12982/cmujns.2021.019
Frimayanti, N., Marzieh, Y., Hamid, N., Ihsan, I., & Meysam, A. (2020a). In silico studies and biological evaluation of chalcone-based 1,5-benzothiazepines as new potential H1N1 neuraminidase inhibitors. Journal of Applied Pharmaceutical Science. 10 (10): 086–094. http://dx.doi.org/10.7324/JAPS.2020.1010010
Frimayanti, N., Ihsan, I., Rahma, D., Tiara, T. A., Fri, M., & Adel, Z. A. (2020b). Computational approach to drug discovery: Search for chalcone analogues as the potential candidates for anti colorectal cancer (HT29). Walailak Journal of Science and Technology. 1(2), 64–74. https://doi.org/10.48048/wjst.2020.5910
Kumar, A., Lal, K., Poonia, N., Ashwani, K., & Anil, K. (2022). Synthesis, antimicrobial evaluation and docking studies of fluorinated imine linked 1,2,3-triazoles. Research on Chemical Intermediates, 48, 2933–2948. https://doi.org/10.1007/s11164-022-04737-2
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46 (1-3), 3–26. https://doi.org/10.1016/s0169-409x(00)00129-0
Oliveira, D., Borges, A., & Simões, M. (2018). Staphylococcus aureus toxins and their molecular activity in infectious diseases. Toxins, 10 (6), 252-271. https://doi.org/10.3390/toxins10060252
Prieto-Martinez, F. D., Arciniega, M., & Medina-Franco, J. L. (2018). Molecular docking: Current advances and challenges. TIP Revista Especializada En Ciencias Químico-Biológicas, 21, 65-87. https://doi.org/10.22201/fesz.23958723e.2018.0.143
Ramírez, D., & Caballero, J. (2018). Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data? Molecules. 23(5), 1038-1055. https://doi.org/10.3390/molecules23051038
Sampath, A., & Padmanabhan, R. (2009). Molecular targets for flavivirus drug discovery. Antiviral Research, 81(1), 6–15. https://doi.org/10.1016/j.antiviral.2008.08.004
Sarfaraz, S., Muneer, I., & Liu, H. (2020). Combining fragment docking with graph theory to improve ligand docking for homology model structures. Journal of Computer-Aided Molecular Design, 34, 1237–1259. https://doi.org/10.1007/s10822-020-00345-7
Tanvir, M. U., Arka, J. C., Ameer, K., Redwan, M. Z., Saikat, M., Talha, B. E., Kuldeep. D., KamalH. R., Márió, G., Muhammad, U.K.S., Jamal, H., & Niranjan, K.(2021). Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. Journal of Infection and Public Health, 14(12), 1750-1766. https://doi.org/10.1016/j.jiph.2021.10.020
Tripathi, A., & Bankaitis, V. A. (2017). Molecular docking: From lock and key to combination lock. Journal of Molecular Medicine and Clinical Applications, 2(1). https://doi.org/10.16966/2575-0305.106
Udo, E. E., Boswihi, S. S., Mathew, B., Noronha, B., &Verghese, T. (2021). Resurgence of chloramphenicol resistance in methicillin-resistant Staphylococcus aureus due to the acquisition of a variant florfenicol exporter (fexAv)-mediated chloramphenicol resistance in Kuwait hospitals. Antibiotics, 10(10), 1250-1265. https://doi.org/10.3390/antibiotics10101250
